Medefil Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEDEFIL INC, and what generic and branded alternatives to MEDEFIL INC drugs are available?
MEDEFIL INC has four approved drugs.
Summary for Medefil Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Medefil Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medefil Inc | STERILE WATER FOR INJECTION | sterile water for injection | LIQUID;N/A | 211188-004 | Dec 2, 2019 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Medefil Inc | SODIUM CHLORIDE 0.9% | sodium chloride | INJECTABLE;INJECTION | 202832-003 | Jan 6, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Medefil Inc | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 214970-001 | Nov 4, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Medefil Inc | STERILE WATER FOR INJECTION | sterile water for injection | LIQUID;N/A | 211188-002 | Dec 2, 2019 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Medefil Inc | SODIUM CHLORIDE 0.9% | sodium chloride | INJECTABLE;INJECTION | 202832-005 | Jan 6, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Medefil Inc | SODIUM CHLORIDE 0.9% | sodium chloride | INJECTABLE;INJECTION | 202832-001 | Jan 6, 2012 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
